Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2015 1
2019 2
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Urgent need to strengthen school health in Asia and the Pacific islands.
Kobayashi J, Takeuchi R, Toyama Y, Gregorio ER Jr, Kadriyan H, Estrada CAM, Motomura M, Wake N, Yamada K, Ishikawa R, Takakura M. Kobayashi J, et al. Among authors: toyama y. Pediatr Int. 2021 Dec;63(12):1419-1423. doi: 10.1111/ped.14921. Epub 2021 Oct 28. Pediatr Int. 2021. PMID: 34258829 Free PMC article. Review.
Comparison Between Contact Force Monitoring and Unipolar Signal Modification as a Guide for Catheter Ablation of Atrial Fibrillation: Prospective Multi-Center Randomized Study.
Ejima K, Kato K, Okada A, Wakisaka O, Kimura R, Ishizawa M, Imai T, Toyama Y, Shoda M, Hagiwara N. Ejima K, et al. Among authors: toyama y. Circ Arrhythm Electrophysiol. 2019 Aug;12(8):e007311. doi: 10.1161/CIRCEP.119.007311. Epub 2019 Jul 26. Circ Arrhythm Electrophysiol. 2019. PMID: 31345092 Free article. Clinical Trial.
Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study -.
Nishii N, Kubo M, Okamoto Y, Fujii S, Watanabe A, Toyama Y, Yamada T, Doi M, Morita H, Ito H; MOMOTARO Investigators. Nishii N, et al. Among authors: toyama y. Circ J. 2015;79(6):1315-22. doi: 10.1253/circj.CJ-15-0076. Epub 2015 Mar 17. Circ J. 2015. PMID: 25787230 Free article.
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Hirose E, Kobayashi Y, Ohkawa K, Ohara M, Takafuji H, Sano F, Toyama Y, Kusachi S, Ohe T, Ito H. Hirohata A, et al. Among authors: toyama y. Atherosclerosis. 2012 Jan;220(1):134-8. doi: 10.1016/j.atherosclerosis.2011.10.013. Epub 2011 Nov 9. Atherosclerosis. 2012. PMID: 22119063 Clinical Trial.